Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Sylvie, Girardon"'
Autor:
Nathalie Dumas, Esther Schenker, Arnaud François, Ross Jeggo, Sylvie Girardon, Laetitia Cistarelli, Catherine Liard, Alain P. Gobert, Gaelle Rollin-Jego, Rodolphe Billiras
Publikováno v:
Alzheimer's & Dementia. 14
Autor:
Nathalie Dumas, Jean-Marie Fourquez, Karine Llopis, Ali Krazem, Philippe Gloanec, Ross Jeggo, Caroline Louis, Sylvie Girardon, Marie Bureau, Guillaume Das Dores, Thierry Pillot, Laurence Danober, Alain Benoist, Catherine Liard, Le Quement Catherine, Thierry Le Diguarher, Daniel Béracochéa, Marc Bertrand, Anne-Marie Chollet
Publikováno v:
Alzheimer's & Dementia. 15:P942-P943
Autor:
Catherine Liard, A. Gobert, Nathalie Dumas, F. Iop, M.J. Millan, Ross Jeggo, V. Pasteau, A. Francois, Rodolphe Billiras, G. Das Dores, Sylvie Girardon, K. Lliopis
Publikováno v:
European Neuropsychopharmacology. 29:S632-S633
Publikováno v:
Psychopharmacology. 225:579-594
Metabotropic glutamate-5 receptors (mGluR5), which physically and functionally interact with N-methyl-D-Aspartate (NMDA) receptors, likewise control cognitive processes and have been proposed as targets for novel classes of antipsychotic agent. Since
Autor:
Clotilde Mannoury la Cour, Manuelle Touzard, Trynke R. deJong, Mauricette Brocco, Sylvie Girardon, Anne Dekeyne, Guillaume de Nanteuil, Millan Mark, Sylvie Veiga, Berend Olivier
Publikováno v:
European Neuropsychopharmacology. 18:729-750
This study characterized the novel neurokinin (NK)(1) antagonist, vestipitant, under clinical evaluation for treatment of anxiety and depression. Vestipitant possessed high affinity for human NK(1) receptors (pK(i), 9.4), and potently blocked Substan
Autor:
Anne Dekeyne, Sylvie Veiga, Loretta Iob, Elisabeth Mocaer, Mauricette Brocco, Martin Egeland, Alan R. Crossman, Carmen Muńoz, Per Svenningsson, Françoise Lejeune, Sylvie Girardon, Michael A. Hill, Benjamin Di Cara, Nitza Thomasson, Millan Mark, Laetitia Cistarelli, Alain Gobert, Charles R. Ashby
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 324:600-611
The novel benzopyranopyrrolidine, S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], is a preferential antagonist of cloned human D(3) versus D(2L) and D(2S) receptors. In mice, S33138
Publikováno v:
Psychopharmacology. 168:397-409
Though 5-HT plays an important role in the modulation of motor function, which is perturbed in depressive states, little is known concerning the influence of serotonin reuptake inhibitors (SSRIs) on locomotor activity (LA). Recently, we demonstrated
Publikováno v:
Pharmacology Biochemistry and Behavior. 71:667-680
This study characterized the influence of acute administration of diverse classes of antidepressant agent upon the spontaneous locomotor activity (LA) of mice in a novel, open-field environment. The selective serotonin (5-HT) reuptake inhibitors (SSR
Publikováno v:
Psychopharmacology. 142:432-434
Rats were trained on a fixed ratio 10, food-reinforced schedule to recognize a discriminative stimulus (DS) elicited by the selective serotonin (5-HT) reuptake inhibitor (SSRI), citalopram (2.5 mg/kg, IP). The preferential, high efficacy agonist at 5
Autor:
Mark J, Millan, Per, Svenningsson, Charles R, Ashby, Michael, Hill, Martin, Egeland, Anne, Dekeyne, Mauricette, Brocco, Benjamin, Di Cara, Françoise, Lejeune, Nitza, Thomasson, Carmen, Munoz, Elisabeth, Mocaër, Alan, Crossman, Laetitia, Cistarelli, Sylvie, Girardon, Loretta, Iob, Sylvie, Veiga, Alain, Gobert
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 324(2)
The novel benzopyranopyrrolidine, S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], is a preferential antagonist of cloned human D(3) versus D(2L) and D(2S) receptors. In mice, S33138